Bentley Pharmaceuticals appoints John A. Sedor President

31-Aug-2005

Bentley Pharmaceuticals, Inc. announced that it has appointed John A. Sedor as its new President, succeeding James R. Murphy, who will remain Chairman and CEO of the Company.

John A. Sedor has a 30-year track record as a successful business leader in the pharmaceutical, biotechnology and consumer products industries. Most recently, he was President and CEO of Sandoz, Inc., and he held similar positions at Verion, Inc., and Centeon, LLC. Other industry experience includes positions at Rhône-Poulenc, Rorer, Revlon Health Care Group, Armour Pharmaceutical Company, and Parke-Davis. He is a past Chairman of the International Plasma Products Industry Association, and a former board member of Quantum Homecare, Applied Immune Sciences and the National Pharmaceutical Council. A veteran of the Vietnam War, Mr. Sedor holds a Bachelor of Science degree from Duquesne University, and has studied strategic marketing at both Northwestern University's Kellogg Graduate School of Management and Harvard University. He has attended Harvard's executive forum as well.

Other news from the department people

Most read news

More news from our other portals

Discover the latest developments in battery technology!